claimedco.com - the verified startup registry

Adjuvant Capital

adjuvantcapital.com · New York (headquarters), San Francisco, Zürich · founded 2018 · team 14 employees total (10+ listed on team page: Glenn Rockman, Jenny Yip, Philippe Dro, Mark Sullivan, Curt LaBelle, Kabeer Aziz, Michael Chang, Joshua Adeoye, Lilly deSouza Burr, Dimple Sahni plus others) · Late-stage clinical (Phase II+) life sciences; clinical trials investment for neglected diseases (vaccines, therapeutics, diagnostics for neglected infectious diseases) · trust 0/4

Using Venture Capital to Improve Global Health

This dossier was built by Clark from a public scan on 2026-07-04 and is unclaimed. Is this your startup? Claim it.

Verified facts

Firm NameAdjuvant Capital
source: https://adjuvantcapital.com
Investment Thesis / TaglineUsing Venture Capital to Improve Global Health
source: https://adjuvantcapital.com
Primary Office LocationsNew York (headquarters), San Francisco, Zürich
source: https://adjuvantcapital.com/team/
Year Founded2018
source: https://www.linkedin.com/company/adjuvant-capital
Team Size (Partners/Employees)14 employees total (10+ listed on team page: Glenn Rockman, Jenny Yip, Philippe Dro, Mark Sullivan, Curt LaBelle, Kabeer Aziz, Michael Chang, Joshua Adeoye, Lilly deSouza Burr, Dimple Sahni plus others)
source: https://www.linkedin.com/company/adjuvant-capital | https://adjuvantcapital.com/team/
Investment StageLate-stage clinical (Phase II+) life sciences; clinical trials investment for neglected diseases (vaccines, therapeutics, diagnostics for neglected infectious diseases)
source: https://adjuvantcapital.com/about/
FoundersGlenn Rockman and Kabeer Aziz (Co-Founders & Partners)
source: https://adjuvantcapital.com/team/
Fund Entity NameADJUVANT GLOBAL HEALTH TECHNOLOGY FUND
source: https://adjuvantcapital.com/about/
Primary Contact Emailyanatos@adjuvantcapital.com
source: https://adjuvantcapital.com/contact/
Assets Under Management$300 million (raised February 18, 2021, announced February 24, 2021)
source: https://adjuvantcapital.com/news/adjuvant-capital-raises-300-million-global-health-venture-fund/
Typical Investment Size$10-25 million per company
source: https://www.linkedin.com/company/adjuvant-capital | https://startupintros.com/startup/adjuvant-capital
Investment Focus AreasNeglected infectious diseases; maternal, newborn, and child health; reproductive and adolescent health; nutrition; vaccines, therapeutics, and diagnostics
source: https://adjuvantcapital.com/about/
Number of Portfolio Companies15+ portfolio companies (LimmaTech Biologics, Memo Therapeutics, Curevo Vaccine, Antiva Biosciences, Pulmocide, Excision BioTherapeutics, Frontier Nutrition, VitriVax, MinervaX, Evofem, Quantoom, LakeShore Biopharma, ChromaCode, 54gene, Codagenix, AN2 Therapeutics, Themis, InDevR, X-Vax)
source: https://adjuvantcapital.com/portfolio/

Open in the registry app →